PICO Portalanswers from OpenAlex
Bevacizumab for recurrent malignant gliomas
PaperCitations, authors & open-access status
Bevacizumab for recurrent malignant gliomas is a paper indexed in PICO Portal from OpenAlex.
How many citations does Bevacizumab for recurrent malignant gliomas have?
PICO Portalcitation count
Bevacizumab for recurrent malignant gliomas has 804 citations in the OpenAlex counts PICO Portal stores.
When was Bevacizumab for recurrent malignant gliomas published?
PICO Portalyear
Bevacizumab for recurrent malignant gliomas has 2008 year in the PICO Portal index.
What is the open-access status of Bevacizumab for recurrent malignant gliomas?
PICO Portaloa status
Bevacizumab for recurrent malignant gliomas has closed oa status in the PICO Portal index.
What is the DOI of Bevacizumab for recurrent malignant gliomas?
PICO Portaldoi
The DOI for Bevacizumab for recurrent malignant gliomas is on the source record.
What is the PMID of Bevacizumab for recurrent malignant gliomas?
PICO Portalpmid
The PMID for Bevacizumab for recurrent malignant gliomas is on the source record.
What is the OpenAlex record for Bevacizumab for recurrent malignant gliomas?
PICO Portalopenalex
The OpenAlex for Bevacizumab for recurrent malignant gliomas is on the source record.